Is CMPX a high-quality business?

AlphaMadera's AlphaQuality grade scores Compass Therapeutics, Inc. on six pillars — profitability, capital efficiency, balance-sheet strength, growth durability, cash generation, and shareholder yield. The composite letter grade reflects how CMPX compares to a Buffett-style quality bar.

What is Compass Therapeutics, Inc.'s AlphaQuality grade?

AlphaQuality assigns a letter grade (A through F) to CMPX based on a six-pillar quantitative model. The live page shows the composite grade plus each pillar's individual score with the underlying metrics.

What makes CMPX a quality stock?

AlphaQuality looks at return on capital, free-cash-flow margins, debt-to-equity, revenue stability, dividend and buyback policy, and operating-margin trend. Stocks scoring well across all six pillars earn higher grades — the methodology favors compounders over cyclicals.

CMPX - Compass Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $11.20 DETAILS

AlphaQuality

Quantitative six-pillar business-quality grade

Distressed or Transitioning

Ungradable

AlphaQuality does not grade distressed or transitioning companies — their quality is dominated by balance-sheet and capital-structure factors outside the scope of this model.